Option Care Corp - OPCH Enterprise Value to EBITDA Ratio
Option Care Health (OPCH) has established a powerful home therapy ecosystem with a closed-loop interaction between physicians and insurers. The company's EV/EBITDA metric on the financial timeline demonstrates business value dynamics, where the value reached 13.83. Its monopoly position in the outpatient sector reduces costs for insurance companies, while a steady stream of payments from chronic patients ensures a sustainable cash flow.
Analytical breakdowns for optioncarehealth.com (OPCH)
- market price and analyst price targets:
- issuer market value details:
- business book valuation details:
- debt obligations and liquidity statistics:
Total Debt to Equity Ratio Option Care Health|OPCH - Long-Term Loans to Capital Ratio|Short-Term Debt to Capital Option Care Health, Inc.|OPCH - Company Total Debt Obligations|Debt to Book Capitalization Ratio Option Care Corp|OPCH - Long-Term Debt|Company Short-Term Debt Option Care Health|Quick Liquidity Indicator optioncarehealth.com
- business earnings and investment ratios data:
OPCH - Final Profit|Projected Future Earnings Option Care Health|OPCH - Price to Earnings Ratio|Forward P/E Multiple Option Care Health|OPCH - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Option Care Corp|OPCH - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) Option Care Health|OPCH - Net earnings per one share for the last twelve months|Year-over-year net earnings per share growth for the last 12 months optioncarehealth.com|OPCH - Earnings per share increase in current year|Earnings growth forecast for next year Option Care Health
Comprehensive company analysis:OPCH (Option Care Health Inc)
Scaling the outpatient therapy network of Option Care Health (OPCH) requires significant capital expenditures, making the enterprise value assessment critical. By analyzing the company's EV/EBITDA multiple, an investor determines the actual value of the business relative to its operating profit before interest, taxes, depreciation, and amortization, which allows for the timely identification of margin recovery and prevents the acquisition of an asset at its peak overvaluation.
Competitor analysis
Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization HCA Healthcare HCA|THC: Enterprise Value to Operating Income Before Depreciation|FMS: Enterprise Value to EBITDA Ratio|solventum.com - Enterprise Value to Operating Income Before Depreciation Ratio|Encompass Health Corporation (EHC) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to EBITDA Universal Health Services, Inc. (UHS)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization DaVita Inc|RadNet Management - Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to EBITDA Ratio SGRY (Surgery Partners, Inc.)|Enterprise Value to Operating Income Before Depreciation Ratio PINC|EV/EBITDA Multiple EYE (National Vision)|Total Company Value to Operating Income Before Depreciation Ratio Progyny Inc (PGNY)|ARDT - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to EBITDA Select Medical Inc.|Astrana Health, Inc. (ASTH) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to Operating Income Before Depreciation MD|Enterprise Value to EBITDA Ratio USPH|PNTG: Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple ORGO|Enterprise Value to EBITDA Ratio Nutex Health Hospitals NUTX|EV/EBITDA Multiple AUNA (Auna SA)|EV/EBITDA Multiple sbc-holdings.com SBC|EOLS - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Business Value to Operating Income Before Depreciation CYH (CHS)|SKIN: EV/EBITDA Multiple|Company Value to EBITDA MediWound (MDWD)|Enterprise Value to EBITDA Ratio BTMD|JYNT: Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple DCGO|PIII (p3hp.org) - Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple GANX (Gain Therapeutics, Inc.)|euda.com (EUDA) - Company Value to EBITDA|Basel Medical Group Limited - EV/EBITDA Multiple|CLGN - EV/EBITDA Multiple|Cuprina Holdings (CUPR) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|CCM (Concord Medical Services Holdings) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio AMS|MRM (MEDIROM Corp) - Enterprise Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple ALBT|DHAI (dih.com) - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Carmell Therapeutics XAGE|NewGenIvf Group (NIVF) - Company Value to EBITDA|ATIP - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio CMAX|KDLY: EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio modivcare.com|NVOS (Novo Integrated Sciences, Inc.) - EV/EBITDA Multiple|SSY: Business Value to Operating Income Before Depreciation|Enterprise Value to EBITDA Ratio BACK (IMAC Regeneration Centers)
